MetLife (MET) Q2 EPS Falls 11%
Werte in diesem Artikel
MetLife (NYSE:MET), a leading global insurance and financial services provider, reported its latest quarterly results on August 6, 2025. The company’s latest earnings release revealed that non-GAAP earnings and revenue trailed Wall Street expectations, with both adjusted (non-GAAP) earnings per share and total revenue missed analyst forecasts. Actual adjusted earnings per share (Non-GAAP) came in at $2.02, versus the anticipated $2.15 (non-GAAP), while GAAP revenue reached $17.34 billion, falling short of the $18.53 billion non-GAAP consensus. Net income (GAAP) dropped to $698 million, down from $912 million in net income (GAAP) for Q2 2024. Despite pressures on profitability, Book value per share increased 7% to $35.79 and adjusted book value per share increased 6% to $56.23. The quarter was marked by weaker-than-expected underwriting, lower investment margins, and Variable investment income decreased. Overall, the company posted a mixed quarter with strength in capital management and international sales, but softness in core profitability. Source: Analyst estimates for the quarter provided by FactSet. MetLife is one of the world’s largest insurance and financial services companies. It operates across several segments, including group benefits, retirement solutions, asset management, and international life and health protection products. Its business model revolves around recurring revenue from insurance premiums, investment income, and asset management fees, with a global scale spanning the United States, Asia, Latin America, and the EMEA (Europe, Middle East, Africa) region.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Übrigens: MetLife und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf MetLife
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf MetLife
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: MotleyFool
Nachrichten zu MetLife Inc.
Analysen zu MetLife Inc.
Datum | Rating | Analyst | |
---|---|---|---|
02.01.2018 | MetLife Hold | Deutsche Bank AG | |
03.11.2017 | MetLife Outperform | RBC Capital Markets | |
25.05.2017 | MetLife Outperform | FBR & Co. | |
09.12.2016 | MetLife Hold | Standpoint Research | |
28.11.2016 | MetLife Mkt Perform | FBR & Co. |
Datum | Rating | Analyst | |
---|---|---|---|
03.11.2017 | MetLife Outperform | RBC Capital Markets | |
25.05.2017 | MetLife Outperform | FBR & Co. | |
05.05.2016 | MetLife Outperform | RBC Capital Markets | |
31.07.2015 | MetLife Buy | Deutsche Bank AG | |
22.06.2015 | MetLife Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
02.01.2018 | MetLife Hold | Deutsche Bank AG | |
09.12.2016 | MetLife Hold | Standpoint Research | |
28.11.2016 | MetLife Mkt Perform | FBR & Co. | |
13.07.2016 | MetLife Hold | Deutsche Bank AG | |
15.03.2016 | MetLife Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
04.12.2006 | Update MetLife Inc.: Underperform | Friedman, Billings Ramsey & Co | |
14.09.2005 | MetLife Downgrade | Deutsche Securities | |
14.09.2005 | Update MetLife Inc.: Sell | Deutsche Securities |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für MetLife Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen